Squarepoint’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Squarepoint’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-37,686	Closed	-$1.25M	–	3010
2020 Q2	$1.25M	Buy	37,686 +25,558	+211%	+$814K	0.02%	827
2020 Q1	$330K	Buy	+12,128	New	+$338K	0.01%	1254
2019 Q4	–	Sell	-22,465	Closed	-$291K	–	2952
2019 Q3	$291K	Sell	22,465 -136,867	-86%	-$1.65M	﹤0.01%	1919
2019 Q2	$1.98M	Sell	159,332 -24,869	-14%	-$330K	0.02%	849
2019 Q1	$2.68M	Buy	184,201 +25,542	+16%	+$326K	0.03%	656
2018 Q4	$1.75M	Buy	+158,659	New	+$2.21M	0.02%	718
2018 Q3	–	Sell	-17,879	Closed	-$366K	–	2334
2018 Q2	$366K	Sell	17,879 -40,251	-69%	-$864K	﹤0.01%	1304
2018 Q1	$1.05M	Buy	58,130 +32,176	+124%	+$536K	0.02%	785
2017 Q4	$362K	Sell	25,954 -8,495	-25%	-$115K	0.01%	1388
2017 Q3	$637K	Sell	34,449 -57,907	-63%	-$968K	0.01%	889
2017 Q2	$1.56M	Buy	+92,356	New	+$1.41M	0.03%	589
2016 Q3	–	Sell	-10,419	Closed	-$113K	–	1369
2016 Q2	$113K	Buy	+10,419	New	+$107K	0.01%	969
2016 Q1	–	Sell	-11,184	Closed	-$166K	–	1557
2015 Q4	$166K	Buy	+11,184	New	+$187K	0.02%	1050

Other funds holding MNTA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return

Squarepoint's MNTA Position: Q3 2020 in Review

Squarepoint sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q3 2020, closing a stake of 37,686 shares — an estimated $1.25M sold.

Squarepoint first reported a position in MNTA in Q4 2015 and held it in 13 quarters. The position peaked at $2.68M in Q1 2019. 211 funds tracked by Wall St. Rank hold MNTA as of Q3 2020.

Squarepoint reported no remaining Momenta Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
Squarepoint sold 37,686 Momenta Pharmaceuticals, Inc. shares in Q3 2020, an estimated $1.25M.
Squarepoint first reported a position in Momenta Pharmaceuticals, Inc. in Q4 2015 and held it in 13 quarters.
Squarepoint's Momenta Pharmaceuticals, Inc. position peaked at $2.68M in Q1 2019.
211 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q3 2020.

Based on Squarepoint's 13F filing for Q3 2020, filed 16 Nov 2020.